Table 3.
Rate Ratio | (95% CI) | Silymarin Complaints/person-visits | Placebo Complaints/person-visits | P-value | |
---|---|---|---|---|---|
Abdominal Pain | 1.01 | (0.50, 2.05) | 17/261 | 15/232 | 0.99 |
Diarrhea | 1.48 | (0.66, 3.57) | 15/263 | 9/236 | 0.35 |
Nausea | 0.89 | (0.27, 2.91) | 6/260 | 6/231 | 0.84 |
Vomiting | 0.55 | (0.10, 2.32) | 3/260 | 5/232 | 0.41 |
Constipation | 0.37 | (0.05, 1.8) | 2/260 | 5/231 | 0.23 |
Increased fatigue | 0.39 | (0.08, 1.45) | 3/260 | 7/231 | 0.16 |
Insomnia | 1.30 | (0.20, 11.2) | 3/260 | 2/231 | 0.78 |
Skin Rash | NA* | -- | 0/260 | 0/231 | NA* |
No participants reported skin rash during follow-up
Methods: rate ratios calculated by median-unbiased estimation and confidence intervals calculated using exact methods.
CI, confidence interval; NA, not applicable